Randomised controlled trial of pharmacist-led patient counselling in controlling hypoglycaemic attacks in older adults with type 2 diabetes mellitus (ROSE-ADAM): A study protocol of the SUGAR intervention

Huda Y Almomani, Carlos Rodriguez Pascual, Sayer I Al-Azzam, Keivan Ahmadi, Huda Y Almomani, Carlos Rodriguez Pascual, Sayer I Al-Azzam, Keivan Ahmadi

Abstract

Introduction: Hypoglycaemia is one of the most serious adverse effects of diabetes treatment. Older adults are at the highest risk to develop hypoglycaemia. Several studies have established the important positive role of educational interventions on achieving glycaemic control and other clinical outcomes, however, there is still a lack in studies that evaluate the impact of such type of interventions on hypoglycaemia risk in elderly patients with type 2 diabetes. The purpose of this research is to evaluate the effectiveness of pharmacist-led patient counselling on reducing hypoglycaemic attacks in older adults with type 2 diabetes mellitus.

Methods: and analysis: This study is an open-label, parallel controlled randomised trial, which will be conducted in the outpatient clinics at the largest referral hospital in the north of Jordan. Participants who are elderly (age ≥ 65 years), diagnosed with type 2 diabetes mellitus, and taking insulin, sulfonylurea, or any three anti-diabetic medications will be randomly assigned to intervention (SUGAR Handshake) and control (usual care) groups. The SUGAR Handshake participants will have an interactive, individualised, medications-focused counselling session reinforced with a pictogram and a phone call at week six of enrolment. The primary outcome measure is the frequency of total hypoglycaemic events within 12 weeks of follow up. Secondary outcomes include the frequency of asymptomatic, symptomatic, and severe hypoglycaemic events, hypoglycaemia incidence, and time to the first hypoglycaemic attack. We will also conduct a nested qualitative study for process evaluation.

Ethics and dissemination: The Human Research Ethics Committee of the University of Lincoln and the Institutional Review Board of King Abdullah University Hospital approved this protocol. The findings of this study will be presented in international conferences and published in a peer-reviewed journal.

Trial registration number: The study protocol has been registered with ClinicalTrials.gov, NCT04081766.

Keywords: Hypoglycemia; Older adults; Patient counselling; Pharmacist; Type 2 diabetes mellitus.

Conflict of interest statement

None.

Copyright © 2020 Elsevier Inc. All rights reserved.

Figures

Fig. 1
Fig. 1
Flow chart of participants during the study.
Fig. 2
Fig. 2
Domains of the SUGAR handshake intervention.
Fig. 3
Fig. 3
SUGAR handshake pictogram.

References

    1. International Hypoglycaemia Study Group Ihs Minimizing hypoglycemia in diabetes. Diabetes Care. 2015 Aug 1;38 [cited 2019 Apr 12] 1583–91. Available from.
    1. Bedenis R., Price A.H., Robertson C.M. Association between severe hypoglycemia, adverse macrovascular events, and inflammation in the edinburgh type 2 diabetes study. Diabetes Care. 2014 Dec 1;37 [cited 2019 Jun 29] 3301–8. Available from.
    1. Fitzpatrick C., Chatterjee S., Seidu S. Association of hypoglycaemia and risk of cardiac arrhythmia in patients with diabetes mellitus: a systematic review and meta-analysis. Diabetes Obes Metab. 2018;20 [cited 2020 Jan 7] 2169–78. Available from.
    1. Lee A.K., Rawlings A.M., Lee C.J. Severe hypoglycaemia, mild cognitive impairment, dementia and brain volumes in older adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) cohort study. Diabetologia. 2018 Sep 1;61 doi: 10.1007/s00125-018-4668-1. [cited 2019 Jun 30] 1956–65. Available from.
    1. Zoungas S, Patel A, Chalmers J Severe hypoglycemia and risks of vascular events and death. N Engl J Med. 2010 Oct 6;363 [cited 2019 Jun 28] 1410–8. Available from.
    1. Davis S.N., Duckworth W., Emanuele N. Effects of severe hypoglycemia on cardiovascular outcomes and death in the veterans affairs diabetes trial. Diabetes Care. 2019 Jan 1;42 [cited 2019 Jun 28] 157–63. Available from.
    1. Bradley C., Eschwège E., Pablos-Velasco P de. Predictors of quality of life and other patient-reported outcomes in the PANORAMA multinational study of people with type 2 diabetes. Diabetes Care. 2018 Feb 1;41 [cited 2019 Jun 30] 267–76. Available from.
    1. Walz L., Pettersson B., Rosenqvist U., Deleskog A., Journath G., Wändell P. Impact of symptomatic hypoglycemia on medication adherence, patient satisfaction with treatment, and glycemic control in patients with type 2 diabetes. Patient Prefer Adherence. 2014 Apr 30;8:593–601. [cited 2019 Jun 30] Available from.
    1. Veronese G., Marchesini G., Forlani G. Costs associated with emergency care and hospitalization for severe hypoglycemia. Nutr Metab Cardiovasc Dis. 2016 Apr 1;26 [cited 2019 Jul 17] 345–51. Available from.
    1. Giorda C.B., Rossi M.C., Ozzello O. Healthcare resource use, direct and indirect costs of hypoglycemia in type 1 and type 2 diabetes, and nationwide projections. Results of the HYPOS-1 study. Nutr Metab Cardiovasc Dis. 2017 Mar 1;27 [cited 2019 Jul 17] 209–16. Available from.
    1. Freeman J. Management of hypoglycemia in older adults with type 2 diabetes. Postgrad Med. 2019 May 19;131 doi: 10.1080/00325481.2019.1578590. [cited 2019 Jul 2] 241–50. Available from.
    1. Sircar M. Review of hypoglycaemia in the older adult: clinical implications and management - Canadian journal of diabetes. Can J Diabetes. 2016;40:66–72. [cited 2019 Feb 15] Available from.
    1. Yun J.-S., Ko S.-H., Ko S.-H. Cardiovascular disease predicts severe hypoglycemia in patients with type 2 diabetes. Diabetes Metab J. 2015 Dec;39:498–506. [cited 2019 Jul 2] Available from.
    1. Clemens K.K., O'Regan N., Rhee J.J. Diabetes management in older adults with chronic kidney disease. Curr Diab Rep. 2019 Feb 15;19:11. doi: 10.1007/s11892-019-1128-3. [cited 2019 Jul 2] Available from.
    1. Association A.D. Older adults: standards of medical care in diabetes—2019. Diabetes Care. 2019 Jan 1;42(Supplement 1) 12. [cited 2019 Jan 18] S139–47. Available from.
    1. The Department of Economic and Social Affairs of the United Nations World economic and social survey, 2007: development in an ageing world. 2007. [cited 2020 Feb 10]. Available from.
    1. Prince M., Wu F., Guo Y. The burden of disease in older people and implications for health policy and practice. The Lancet. 2015;385 [cited 2020 Feb 10] 549–62. Available from.
    1. Ajlouni K., Khader Y.S., Batieha A., Ajlouni H., El-Khateeb M. An increase in prevalence of diabetes mellitus in Jordan over 10 years. J Diabetes Complications. 2008 Sep 1;22 [cited 2018 Dec 19] 317–24. Available from.
    1. The United Nations . The United Nations; 2017. World Population Aging 2017- Highlights. Available from.
    1. Al-Sahouri A, Merrell J, Snelgrove S Attitudes, knowledge, and perceptions of patients regarding type-2 diabetes in Jordan. J Diabetes Mellit. 2019 Feb 12 [cited 2019 Mar 17];09:1. Available from.
    1. Naser A.Y., Wong I.C.K., Whittlesea C. Attitudes and perceptions towards hypoglycaemia in patients with diabetes mellitus: a multinational cross-sectional study. PLOS ONE. 2019 Oct 24;14:e0222275. [cited 2019 Nov 24] Available from.
    1. Al-Keilani M.S., Almomani B.A., Al-Sawalha N.A., Shhabat B.A. Self-monitoring of blood glucose among patients with diabetes in Jordan: perception, adherence, and influential factors. Diabetes Res Clin Pract. 2017 Apr 1;126:79–85. [cited 2019 Nov 24] Available from.
    1. Jarab A.S., Mukattash T.L., Al-Azayzih A., Khdour M. A focus group study of patient's perspective and experiences of type 2 diabetes and its management in Jordan. Saudi Pharm J SPJ. 2018 Mar;26 [cited 2019 Nov 25] 301–5. Available from.
    1. Bukhsh A., Tan X.Y., Chan K.G., Lee L.-H., Goh B.-H., Khan T.M. Effectiveness of pharmacist-led educational interventions on self-care activities and glycemic control of type 2 diabetes patients: a systematic review and meta-analysis. Patient Prefer Adherence. 2018 Nov 21;12 [cited 2019 Jul 11] 2457–74. Available from.
    1. Korcegez E.I., Sancar M., Demirkan K. Effect of a pharmacist-led program on improving outcomes in patients with type 2 diabetes mellitus from northern Cyprus: a randomized controlled trial. J Manag Care Spec Pharm. 2017 Apr 27;23 [cited 2019 Mar 15] 573–82. Available from.
    1. Jahangard-Rafsanjani Z., Sarayani A., Nosrati M. Effect of a community pharmacist–delivered diabetes support program for patients receiving specialty medical care: a randomized controlled trial. Diabetes Educ. 2015 Feb;41 [cited 2019 May 3] 127–35. Available from.
    1. Shareef J., Fern J.C.W., Es, Samaga L. 2016. Impact of pharmacist's intervention on improving quality of life in patients with diabetes mellitus.
    1. Hassali M.A.A., Nazir S.U.R., Saleem F., Masood I. Literature review: pharmacists' interventions to improve control and management in type 2 diabetes mellitus. Altern Ther Health Med [Internet] 2015 Feb 1;21:28–35. [cited 2019 Jul 13] Available from.
    1. Subramanian S., Hirsch I.B. Personalized diabetes management: moving from algorithmic to individualized therapy. Diabetes Spectr. 2014 May 1;27:87–91. [cited 2020 Jan 20] Available from.
    1. Jiang X., Wang J., Lu Y., Jiang H., Li M. Self-efficacy-focused education in persons with diabetes: a systematic review and meta-analysis. Psychol Res Behav Manag [Internet] 2019;12:67–79. [cited 2019 Aug 23] Available from.
    1. Iqbal A., Heller S.R. The role of structured education in the management of hypoglycaemia. Diabetologia. 2018;61:751–760. Available from.
    1. Alefan Q., Alsmadi M. Pharmacy education in Jordan: updates. Int J Pharm Pract. 2017;25 [cited 2020 Feb 10] 418–20. Available from.
    1. Petticrew M. When are complex interventions ‘complex’? When are simple interventions ‘simple’? Eur J Public Health. 2011;21 [cited 2020 Feb 10] 397–8. Available from.
    1. Craig P., Dieppe P., Macintyre S., Michie S., Nazareth I., Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. 2008 Sep 29;337:a1655. [cited 2019 Oct 27] Available from.
    1. Moore G.F., Audrey S., Barker M. Process evaluation of complex interventions: Medical Research Council guidance. BMJ. 2015 Mar 19;350:h1258. [cited 2019 Oct 27] Available from.
    1. Chan A.-W., Tetzlaff J.M., Altman D.G. SPIRIT 2013 Statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158:200–207.
    1. Balijepalli C., Druyts E., Siliman G., Joffres M., Thorlund K., Mills E.J. Hypoglycemia: a review of definitions used in clinical trials evaluating antihyperglycemic drugs for diabetes. Clin Epidemiol. 2017 May 23;9 [cited 2019 Jan 23] 291–6. Available from.
    1. Elliott L., Fidler C., Ditchfield A., Stissing T. Hypoglycemia event rates: a comparison between real-world data and randomized controlled trial populations in insulin-treated diabetes. Diabetes Ther. 2016 Mar;7:45–60. [cited 2019 Jan 24] Available from.
    1. Yong Y.-M., Shin K.-M., Lee K.-M. Intensive individualized reinforcement education is important for the prevention of hypoglycemia in patients with type 2 diabetes. Diabetes Metab J. 2015 Apr;39 [cited 2019 Apr 27] 154–63. Available from.
    1. Sample size calculator. [cited 2019 Aug 28], Available from.
    1. Michie S., van Stralen M.M., West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci IS. 2011 Apr 23;6:42. [cited 2019 Oct 16] Available from.
    1. Hoffmann T.C., Glasziou P.P., Boutron I. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 2014 Mar 7;348:g1687. [cited 2019 Apr 23] Available from.
    1. Seaquist E.R., Anderson J., Childs B. Hypoglycemia and diabetes: a report of a workgroup of the American diabetes association and the endocrine society. Diabetes Care. 2013 May;36 [cited 2018 Dec 15] 1384–95. Available from.
    1. Braatvedt G.D., Cundy T., Crooke M. Understanding the new HbA1c units for the diagnosis of Type 2 diabetes. N Z Med J. 2012 Sep 21;125:70–80. [cited 2020 Jan 8] Available from.
    1. Moore G., Audrey S., Barker M. UK medical research Council (MRC) guidance. MRC Popul Health Sci Res. 2015;134 [cited 2019 Oct 27] Available from.
    1. Rich J.T., Neely J.G., Paniello R.C., Voelker C.C.J., Nussenbaum B., Wang E.W. A practical guide to understanding kaplan-meier curves. Otolaryngol--Head Neck Surg Off J Am Acad Otolaryngol-Head Neck Surg. 2010 Sep;143 [cited 2020 Feb 12] 331–6. Available from.
    1. Kang H. The prevention and handling of the missing data. Korean J Anesthesiol. 2013 May;64 [cited 2020 Feb 12] 402–6. Available from.
    1. Ditlhong K.E., Ngesa O.O., Kombo A.Y. A comparative analysis of generalized estimating equations methods for incomplete longitudinal ordinal data with ignorable dropouts. Open J Stat. 2018 Sep 10;8 [cited 2020 Feb 12] 770–92. Available from.
    1. Braun V., Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77–101. Available from.
    1. Lorig K., Ritter P.L., Villa F.J., Armas J. Community-based peer-led diabetes self-management. Diabetes Educ. 2009 Jul;35 [cited 2019 Apr 27] 641–51. Available from.
    1. Rondags S.M.P.A., Wit M de, Twisk J.W., Snoek F.J. Effectiveness of HypoAware, a brief partly web-based psychoeducational intervention for adults with type 1 and insulin-treated type 2 diabetes and problematic hypoglycemia: a cluster randomized controlled trial. Diabetes Care. 2016 Dec 1;39 [cited 2019 Jul 27] 2190–6. Available from.
    1. Guo Efficacy of structured education in patients with type 2 diabetes mellitus receiving insulin treatment. J Diabetes. 2013;6 [cited 2019 Jul 27] 290–7. Available from.
    1. Deakin T.A., Cade J.E., Williams R., Greenwood D.C. Structured patient education: the Diabetes X-PERT Programme makes a difference. Diabet Med. 2006 Sep 1;23 [cited 2019 Jul 27] 944–54. Available from.
    1. Hermanns N., Ehrmann D., Schall S., Maier B., Haak T., Kulzer B. The effect of an education programme (MEDIAS 2 BSC) of non-intensive insulin treatment regimens for people with Type 2 diabetes: a randomized, multi-centre trial. Diabet Med. 2017;34 [cited 2019 Jul 27] 1084–91. Available from.
    1. Cruz‐Jentoft A.J., Carpena‐Ruiz M., Montero‐Errasquín B., Sánchez‐Castellano C., Sánchez‐García E. Exclusion of older adults from ongoing clinical trials about type 2 diabetes mellitus. J Am Geriatr Soc. 2013;61 [cited 2019 Jan 20] 734–8. Available from.
    1. Wright S.M., Hedin S.C., McConnell M. Using shared decision-making to address possible overtreatment in patients at high risk for hypoglycemia: the veterans health administration's choosing wisely hypoglycemia safety initiative. Clin Diabetes Publ Am Diabetes Assoc. 2018 Apr;36 [cited 2019 Aug 27] 120–7. Available from.
    1. McKenzie A.L., Hallberg S.J., Creighton B.C. A novel intervention including individualized nutritional recommendations reduces hemoglobin A1c level, medication use, and weight in type 2 diabetes. JMIR Diabetes. 2017;2:e5. [cited 2020 Jan 8] Available from.
    1. Ajlouni K., Batieha A., Jaddou H. Time trends in diabetes mellitus in Jordan between 1994 and 2017. Diabet Med. 2019 [cited 2019 Mar 14];0. Available from.
    1. Nazer L.H., Tuffaha H. Health care and pharmacy practice in Jordan. Can J Hosp Pharm. 2017;70 [cited 2019 Mar 16] 150–5. Available from.
    1. [Internet]. National Library of Medicine (US) Identifier NCT04081766, pharmacist-led study in controlling hypoglycemia in older adults with type 2 diabetes mellitus (ROSE-ADAM) 2000 Feb 29. 2019 Sep 9; [cited 2020 Mar 11]; [about 7 screens]. Available from.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit